Redefining the Prognostic Value of High-Sensitivity Troponin in COVID-19 Patients: The Importance of Concomitant Coronary Artery Disease

Journal of Clinical Medicine

23 October Oct 2020 one month ago
  • Bartorelli AL, Tondo C

Although studies assessing cardiovascular comorbidities and myocardial injury in Coronavirus disease 2019 (COVID-19) patients have been published, no reports focused on clinical outcomes of myocardial injury in patients with and without chronic coronary syndromes (CCS) are currently available.

Reference

Schiavone M, Gasperetti A, Mancone M, Kaplan AV, Gobbi C, Mascioli G, Busana M, Saguner AM, Mitacchione G, Giacomelli A, Sardella G, Viecca M, Duru F, Antinori S, Carugo S, Bartorelli AL, Tondo C, Galli M, Fedele F, Forleo GB. Redefining the Prognostic Value of High-Sensitivity Troponin in COVID-19 Patients: The Importance of Concomitant Coronary Artery Disease. J Clin Med 2020 Oct 12;9(10):E3263. doi: 10.3390/jcm9103263.

Go to PubMed